[1] Yonesaka K,Haratani K,Takamura S,et al.B7-H3 Negatively modulates CTL-mediated cancer immunity. Clin Cancer Res,2018,24(11):2653-2664. [2] Guan X,Liu Z,Zhang J,et al. Myeloid-derived suppressor cell accumulation in renal cell carcinoma is correlated with CCL2,IL-17 and IL-18 expression in blood and tumors. Adv Clin Exp Med,2018[ahead of print]. [3] Okuhara Y,Yokoe S,Asahi M,et al.Interleukin-18 in cardiomyocyte:A novel therapeutic target for attenuating cardiac remodeling response. Int J Cardiol,2018,266:221. [4] 曾波,李彦. 慢性乙型肝炎和肝硬化患者血清骨桥蛋白和TGF- β1水平变化. 实用肝脏病杂志,2017,20(2):240-241. [5] 马晨,孙海洪,李淑香,等. B7-H3信号对不同活化状态T细胞产生免疫应答的差异性研究. 中华微生物学和免疫学杂志,2017,37(3):183-187. [6] 王斐斐,于国华,刘同慎,等. 可溶型B7-H3在原发性肝细胞癌患者血清中的表达及临床意义. 细胞与分子免疫学杂志,2013,29(6):629-632. [7] Flem-Karlsen K,Fodstad O,Tan M,et al.B7-H3 in cancer- beyond immune regulation. Trends Cancer,2018,4(6):401-404. [8] Xu Z,Wang L,Tian J,et al.High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder. Oncol Lett,2018,15(5):6519-6526. [9] Varki V,Ioffe OB,Bentzen SM,et al.PD-L1,B7-H3,and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma. Cancer Immunol Immunother,2018,67(5):805-814. [10] Wei X,Li K,Zhang G,et al.B7-H3 promoted proliferation of mouse spermatogonial stem cells via the PI3K signaling pathway. Oncotarget,2018,9(2):1542-1552. [11] Luan Y,Ju J,Luo L,et al.Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection. J Viral Hepat,2012,19(1):23-31. [12] Dinarello CA,Kaplanski G. Indeed, IL-18 is more than an inducer of IFN-gamma. J Leukoc Biol,2018[ahead of print]. [13] Ma K,Zhang HX, Baloch Z.Pathogenetic and therapeutic applications of tumor necrosis factor-α(TNF-α) in major depressive disorder:A systematic review. Int J Mol Sci,2016,17(5):733. [14] Buechler C,Haberl EM,Rein-Fischboeck L,et al.A dipokines in liver cirrhosis. Int J Mol Sci,2017,18(7):1392. [15] Mcclain KL,Allen CE.Fire behind the fury:IL-18 and MAS. Blood,2018,131(13):1393-1394. [16] Nakamura K,Kassem S,Cleynen A,et al.Dysregulated IL-18 is a key driver of immunosuppression and a possible therapeutic target in the multiple myeloma microenvironment. Cancer Cell,2018,33(4):634-648. [17] Lee S,Kim DY.Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol,2014,20(2):445-459. [18] Gatault S,Delbeke M,Driss V,et al.IL-18 is involved in eosinophil-mediated tumoricidal activity against a colon carcinoma cell line by upregulating LFA-1 and ICAM-1. J Immunol,2015,195(5):2483-2492. [19] Nagai H,Mukozu T,Kanekawa T,et al.Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy. Hepatogastroenterology,2013,60(124):858-863. [20] Silvain C,Patry C,Launay P,et al.Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma. J Immunol,1995,155(3):1606-1618. [21] Luo L,Zhu G,Xu H,et al.B7-H3 promotes pathogenesis of autoimmune disease and inflammation by regulating the activity of different T cell subsets. PLoS One,2015,10(6):e130126. [22] Conroy MJ,Mac NR,Taylor M,et al.Increased frequencies of circulating IFN-gamma-producing Vdelta1(+) and Vdelta2(+) gammadelta T cells in patients with asymptomatic persistent hepatitis B virus infection. Viral Immunol,2015,28(4):201-208. [23] Mokdad AA,Lopez AD,Shahraz S,et al.Liver cirrhosis mortality in 187 countries between 1980 and 2010:a systematic analysis. BMC Med,2014,12:145. |